-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Reiterates Buy on Gilead Sciences, Maintains $170 Price Target

Benzinga·08/05/2026 10:02:07
Listen to the news
Needham analyst Joseph Stringer reiterates Gilead Sciences (NASDAQ:GILD) with a Buy and maintains $170 price target.